AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 51 min read$HNGE

Hinge Health, Inc. (HNGE) Sets Q3 2026 Earnings Release for Nov. 2

Hinge Health, Inc. (HNGE) announced it will release Q3 2026 earnings after market close on Nov. 2, 2026, followed by a conference call at 4:30 p.m. ET. The details will be available on the company's investor relations website.

Original reporting
tradingview.com
Published Oct 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 4:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Hinge Health, Inc. (HNGE) Sets Q3 2026 Earnings Release for Nov. 2 — source image
Source · tradingview.com
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The date announcement itself offers little actionable insight; the real trading catalyst will be the earnings numbers and guidance when released.

02

Market read

Low relevance until the earnings results are published.

03

What to watch

Potential hidden guidance or strategic announcements that could be embedded in the earnings call.

Relevance 4/10Novelty 2/10Timing: Nov 2 after market close

Background

Hinge Health is a digital health company focused on musculoskeletal care. The article is a simple press‑release style notice of its upcoming earnings release date.

Company-level read

Ticker impact

$HNGENeutralHigh confidence
Context

Hinge Health announced its Q3 2026 earnings will be released after market close on Nov. 2, 2026.

Expected impact

minimal impact until the actual earnings results are disclosed

Evidence & confidence

Date announcements typically have little immediate price effect; traders will wait for the earnings numbers.

Market effects

Sector

None significant; the announcement does not affect the broader digital health sector.

Regional

None

Global

Low

Counterpoint

What could challenge this read

If investors anticipate a surprise in the upcoming earnings, they might position ahead of the release despite the routine nature of the date announcement.

Key entities

  • Company
    Hinge Health, Inc.

    Digital health provider announcing its Q3 2026 earnings release date.

Read at source← All news

Related articles

AUG 28
$HNGEHighAI 8/10

Could Hinge Health (HNGE) Stock Win as Digital Healthcare Expands Beyond MSK Care?

Hinge Health (NYSE:HNGE) raised its 2026 revenue guidance to $856M-$860M, up from $822.16M consensus. Q2 2026 revenue grew 53% YoY to $213M, with non-GAAP operating income doubling to $62M. The company announced a $105M acquisition of Cylinder Health and expanded its share repurchase program by $300M. Analysts RBC and Truist raised price targets to $110 and $112, respectively, citing strong growth and platform expansion.

finance.yahoo.com3 min
AUG 19
$HNGEMedAI 8/10

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health (HNGE) stock has risen 90% YTD, outperforming industry and S&P 500. Q2 revenue grew 53% YoY to $213M, with 2026 guidance raised to $856-$860M. AI and automation improved margins, while new care programs expand market reach. Analysts project 2026 EPS of $2.50 and 2027 EPS of $3.29. Growth is driven by member yield, AI efficiency, and new care offerings, but execution risks remain.

zacks.com3 min
AUG 15
$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.

yahoo.com6 min
AUG 12
$HNGEMed

Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?

Hinge Health (NASDAQ:HNGE) reported Q2 revenue of $213 million, up 53% year over year, above guidance of $200 million to $202 million. Gross margin rose to 87% and operating income to $62 million. The company said it used $105 million cash to acquire Cylinder Health for gastrointestinal care, while also expanding its migraine offering. It raised FY revenue guidance to $856 million to $860 million and authorized a $300 million buyback.

insidermonkey.com7 min
AUG 5
$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

investing.com4 min